Cysteine protease inhibitors

Compounds of the formula (I) wherein R is H; and R is C-Calkyl, Carbocyclyl or Het; or R and R together define a saturated cyclic amine with 3-6 ring atoms; R and R are independently H, halo, C-Calkyl, C-Chaloalkyl or C-Calkoxy, or R and R together with the carbon atom to which they are attached for...

Full description

Saved in:
Bibliographic Details
Main Authors AYESA, SUSANA, CARLQUIST, PETER, KLASSON, BJORN, KAHNBERG, PIA, GRABOWSKA, URSZULA, HEWITT, ELLEN, WIKTELIUS, DANIEL, ERSMARK, KAROLINA, LIND, PETER, JONSSON, DANIEL, ODEN, LOURDES, PARKES, KEVIN
Format Patent
LanguageEnglish
Published 14.06.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of the formula (I) wherein R is H; and R is C-Calkyl, Carbocyclyl or Het; or R and R together define a saturated cyclic amine with 3-6 ring atoms; R and R are independently H, halo, C-Calkyl, C-Chaloalkyl or C-Calkoxy, or R and R together with the carbon atom to which they are attached form a C-Ccycloalkyl; R is a branched C-C alkyl chain, C-Chaloalkyl or -CHC-C cycloalkyl; R is C-Calkyl, C-Chaloalkyl, C-Calkylamino or C-Cdialkylamino; for use in the prophylaxis or treatment of a disorder characterised by inappropriate expression or activation of cathepsin S.
Bibliography:Application Number: AU20100329470